Through a genome-wide association study of gene-environment interaction, we previously identified genetic variants (GRIN2B, DCBLD1) that modified CRC risk associated with MHT use, offering new insights into pathways of CRC carcinogenesis and potential mechanisms involved [16]. Here, GRIN2B is linked to colorectal carcinoma.